[
    {
        "molecule_name": "BMY7378",
        "protein_target_name": "α1D adrenoceptor",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "KB",
        "value": "2.95",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences with specific molecule names, bioactivity metrics, numeric values, and units:\n\n1. We conducted experiments with BMY7378 50 nM, α1D adrenoceptor antagonist used as positive control, and obtained a value of KB = 2.95 nM, consistent with the literature (CARROLL et al, Bioorg Med Chem Lett, 11:1119 - 1121, 2001).\n2. Compared with BMY7378 (KB=2.95 nM) affinity for this receptor is greater for the LDT derivative 5 and 8 (KB = 0.57 and 0.16, respectively, * P &lt;0.05).\n3. For the calculation of the Ki of the LTD's it was used the Cheng-Prusoff equation, where for prazosin (PZS) Kd values were 0.46 nM and 56.5 nM for sites of high and low affinity, respectively to α1A adrenoceptor, and it was used Kd = 0.34 nM for α1B-adrenoceptor.\n4. Kd values of [3H]-prazosin to α1A adrenoceptors were 0.46 nM and 56.5 nM for sites with high and low affinities, respectively (n = 3), and α1B adrenoceptors the Kd value was 0,34 nM (n = 3), in agreement with literature (SHIBATA and cols., Mol. Pharmacol., 48:250-258, 1995).\n5. The competition curve was biphasic in preparation of rabbit liver, approximately 2/3 of the sites labeled by 0.1 nM [3H]-prazosin showing high affinity for prazosin (CI50 = 0.16 nM) and 1 / 3 had low affinity sites (CI50 1 nM).\n6. Table 1: ... LDT5 b-7,12 ± 0,22-5,85 ± 0,1518,5 ± 2,5-9,23 ± 0,06 *0,5766 aNDNDNDNDND\n7. Table 2: ... LDT66-6,78 ± 0,08-5,29 ± 0,0732-8,78 ± 0,06a1,664\n8. Table 3: ... LDT24-7,72 ± 0,261,57 x 10-834-8,25 ± 0,674,63 x 10-943-7,97 ± 0,798,81 x 10-953-8,35 ± 0,203,67 x 10-963-8,58 ± 0,342,16 x 10-984-8,34 ± 0,713,76 x 10-9\n9. Table 5: ... LDTα 1A (n)α 1B (n)log IC50 (M)Ki (nM)log IC50 (M)Ki (nM)62-6,51 ± 0,2261 (4)-6,27 ± 0,05448 (3)\n10. Table 6: ... LDT65-5,60 ± 0,061,5(5)66-5,92 ± 0,060,8(5)67-6,10 ± 0,060,5(5)68-6,01 ± 0,030,6(5)\n11. Table 7: ... LDTnlog CI50 ± EPM (M) aKi (M) b24-8,52 ± 0,03 **1,24 x 10-934-8,56 ± 0,07 **1,13 x 10-944-8,62 ± 0,13 **9,88 x 10-1054-8,21 ± 0,05**2,54 x 10-964-9,23 ± 0,24 *2,42 x 10-1083-10,24 ± 0,712,37 x 10-112452-8,03 ± 0,053,80 x 10-9\n12. Table 8: ... LDT5-HT1A (n)log IC50 (M)Ki (nM)62-6,47 ± 0,10147 (3)63-6,37 ± 0,03191 (3)64-6,72 ± 0,1984 (3)65-7,42 ± 0,09c18 (3)\n13. Table 10: ... LDTnlog CI50 ± EPM (M) aKi (M) b23-7,13 ± 0,114,74 x 10-833-7,15 ± 0,224,52 x 10-843-7,16 ± 0,064,42 x 10-853-6,41 ± 0,022,48 x 10-763-6,23 ± 0,463,76 x 10-783-6,41 ± 0,702,48 x 10-7\n14. Table 11: ... 5-HT2A (n)LDTlog IC50 (M)Ki (nM)62-5,00 ± 0,166,41 (3)63-4,86 ± 0,138,85 (4)64-5,06 ± 0,095,58 (3)65-5,34 ± 0,092,93 (4)\n\nNote that some of these sentences are from tables, and the formatting may not be perfect. Let me know if you'd like me to help with anything else!"
    },
    {
        "molecule_name": "Prazosin (PZS)",
        "protein_target_name": "α1A adrenoceptor",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "Kd",
        "value": "0.46",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences with specific molecule names, bioactivity metrics, numeric values, and units:\n\n1. We conducted experiments with BMY7378 50 nM, α1D adrenoceptor antagonist used as positive control, and obtained a value of KB = 2.95 nM, consistent with the literature (CARROLL et al, Bioorg Med Chem Lett, 11:1119 - 1121, 2001).\n2. Compared with BMY7378 (KB=2.95 nM) affinity for this receptor is greater for the LDT derivative 5 and 8 (KB = 0.57 and 0.16, respectively, * P &lt;0.05).\n3. For the calculation of the Ki of the LTD's it was used the Cheng-Prusoff equation, where for prazosin (PZS) Kd values were 0.46 nM and 56.5 nM for sites of high and low affinity, respectively to α1A adrenoceptor, and it was used Kd = 0.34 nM for α1B-adrenoceptor.\n4. Kd values of [3H]-prazosin to α1A adrenoceptors were 0.46 nM and 56.5 nM for sites with high and low affinities, respectively (n = 3), and α1B adrenoceptors the Kd value was 0,34 nM (n = 3), in agreement with literature (SHIBATA and cols., Mol. Pharmacol., 48:250-258, 1995).\n5. The competition curve was biphasic in preparation of rabbit liver, approximately 2/3 of the sites labeled by 0.1 nM [3H]-prazosin showing high affinity for prazosin (CI50 = 0.16 nM) and 1 / 3 had low affinity sites (CI50 1 nM).\n6. Table 1: ... LDT5 b-7,12 ± 0,22-5,85 ± 0,1518,5 ± 2,5-9,23 ± 0,06 *0,5766 aNDNDNDNDND\n7. Table 2: ... LDT66-6,78 ± 0,08-5,29 ± 0,0732-8,78 ± 0,06a1,664\n8. Table 3: ... LDT24-7,72 ± 0,261,57 x 10-834-8,25 ± 0,674,63 x 10-943-7,97 ± 0,798,81 x 10-953-8,35 ± 0,203,67 x 10-963-8,58 ± 0,342,16 x 10-984-8,34 ± 0,713,76 x 10-9\n9. Table 5: ... LDTα 1A (n)α 1B (n)log IC50 (M)Ki (nM)log IC50 (M)Ki (nM)62-6,51 ± 0,2261 (4)-6,27 ± 0,05448 (3)\n10. Table 6: ... LDT65-5,60 ± 0,061,5(5)66-5,92 ± 0,060,8(5)67-6,10 ± 0,060,5(5)68-6,01 ± 0,030,6(5)\n11. Table 7: ... LDTnlog CI50 ± EPM (M) aKi (M) b24-8,52 ± 0,03 **1,24 x 10-934-8,56 ± 0,07 **1,13 x 10-944-8,62 ± 0,13 **9,88 x 10-1054-8,21 ± 0,05**2,54 x 10-964-9,23 ± 0,24 *2,42 x 10-1083-10,24 ± 0,712,37 x 10-112452-8,03 ± 0,053,80 x 10-9\n12. Table 8: ... LDT5-HT1A (n)log IC50 (M)Ki (nM)62-6,47 ± 0,10147 (3)63-6,37 ± 0,03191 (3)64-6,72 ± 0,1984 (3)65-7,42 ± 0,09c18 (3)\n13. Table 10: ... LDTnlog CI50 ± EPM (M) aKi (M) b23-7,13 ± 0,114,74 x 10-833-7,15 ± 0,224,52 x 10-843-7,16 ± 0,064,42 x 10-853-6,41 ± 0,022,48 x 10-763-6,23 ± 0,463,76 x 10-783-6,41 ± 0,702,48 x 10-7\n14. Table 11: ... 5-HT2A (n)LDTlog IC50 (M)Ki (nM)62-5,00 ± 0,166,41 (3)63-4,86 ± 0,138,85 (4)64-5,06 ± 0,095,58 (3)65-5,34 ± 0,092,93 (4)\n\nNote that some of these sentences are from tables, and the formatting may not be perfect. Let me know if you'd like me to help with anything else!"
    },
    {
        "molecule_name": "Prazosin (PZS)",
        "protein_target_name": "α1A adrenoceptor",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "Kd",
        "value": "56.5",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences with specific molecule names, bioactivity metrics, numeric values, and units:\n\n1. We conducted experiments with BMY7378 50 nM, α1D adrenoceptor antagonist used as positive control, and obtained a value of KB = 2.95 nM, consistent with the literature (CARROLL et al, Bioorg Med Chem Lett, 11:1119 - 1121, 2001).\n2. Compared with BMY7378 (KB=2.95 nM) affinity for this receptor is greater for the LDT derivative 5 and 8 (KB = 0.57 and 0.16, respectively, * P &lt;0.05).\n3. For the calculation of the Ki of the LTD's it was used the Cheng-Prusoff equation, where for prazosin (PZS) Kd values were 0.46 nM and 56.5 nM for sites of high and low affinity, respectively to α1A adrenoceptor, and it was used Kd = 0.34 nM for α1B-adrenoceptor.\n4. Kd values of [3H]-prazosin to α1A adrenoceptors were 0.46 nM and 56.5 nM for sites with high and low affinities, respectively (n = 3), and α1B adrenoceptors the Kd value was 0,34 nM (n = 3), in agreement with literature (SHIBATA and cols., Mol. Pharmacol., 48:250-258, 1995).\n5. The competition curve was biphasic in preparation of rabbit liver, approximately 2/3 of the sites labeled by 0.1 nM [3H]-prazosin showing high affinity for prazosin (CI50 = 0.16 nM) and 1 / 3 had low affinity sites (CI50 1 nM).\n6. Table 1: ... LDT5 b-7,12 ± 0,22-5,85 ± 0,1518,5 ± 2,5-9,23 ± 0,06 *0,5766 aNDNDNDNDND\n7. Table 2: ... LDT66-6,78 ± 0,08-5,29 ± 0,0732-8,78 ± 0,06a1,664\n8. Table 3: ... LDT24-7,72 ± 0,261,57 x 10-834-8,25 ± 0,674,63 x 10-943-7,97 ± 0,798,81 x 10-953-8,35 ± 0,203,67 x 10-963-8,58 ± 0,342,16 x 10-984-8,34 ± 0,713,76 x 10-9\n9. Table 5: ... LDTα 1A (n)α 1B (n)log IC50 (M)Ki (nM)log IC50 (M)Ki (nM)62-6,51 ± 0,2261 (4)-6,27 ± 0,05448 (3)\n10. Table 6: ... LDT65-5,60 ± 0,061,5(5)66-5,92 ± 0,060,8(5)67-6,10 ± 0,060,5(5)68-6,01 ± 0,030,6(5)\n11. Table 7: ... LDTnlog CI50 ± EPM (M) aKi (M) b24-8,52 ± 0,03 **1,24 x 10-934-8,56 ± 0,07 **1,13 x 10-944-8,62 ± 0,13 **9,88 x 10-1054-8,21 ± 0,05**2,54 x 10-964-9,23 ± 0,24 *2,42 x 10-1083-10,24 ± 0,712,37 x 10-112452-8,03 ± 0,053,80 x 10-9\n12. Table 8: ... LDT5-HT1A (n)log IC50 (M)Ki (nM)62-6,47 ± 0,10147 (3)63-6,37 ± 0,03191 (3)64-6,72 ± 0,1984 (3)65-7,42 ± 0,09c18 (3)\n13. Table 10: ... LDTnlog CI50 ± EPM (M) aKi (M) b23-7,13 ± 0,114,74 x 10-833-7,15 ± 0,224,52 x 10-843-7,16 ± 0,064,42 x 10-853-6,41 ± 0,022,48 x 10-763-6,23 ± 0,463,76 x 10-783-6,41 ± 0,702,48 x 10-7\n14. Table 11: ... 5-HT2A (n)LDTlog IC50 (M)Ki (nM)62-5,00 ± 0,166,41 (3)63-4,86 ± 0,138,85 (4)64-5,06 ± 0,095,58 (3)65-5,34 ± 0,092,93 (4)\n\nNote that some of these sentences are from tables, and the formatting may not be perfect. Let me know if you'd like me to help with anything else!"
    },
    {
        "molecule_name": "Prazosin (PZS)",
        "protein_target_name": "α1B-adrenoceptor",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "Kd",
        "value": "0.34",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences with specific molecule names, bioactivity metrics, numeric values, and units:\n\n1. We conducted experiments with BMY7378 50 nM, α1D adrenoceptor antagonist used as positive control, and obtained a value of KB = 2.95 nM, consistent with the literature (CARROLL et al, Bioorg Med Chem Lett, 11:1119 - 1121, 2001).\n2. Compared with BMY7378 (KB=2.95 nM) affinity for this receptor is greater for the LDT derivative 5 and 8 (KB = 0.57 and 0.16, respectively, * P &lt;0.05).\n3. For the calculation of the Ki of the LTD's it was used the Cheng-Prusoff equation, where for prazosin (PZS) Kd values were 0.46 nM and 56.5 nM for sites of high and low affinity, respectively to α1A adrenoceptor, and it was used Kd = 0.34 nM for α1B-adrenoceptor.\n4. Kd values of [3H]-prazosin to α1A adrenoceptors were 0.46 nM and 56.5 nM for sites with high and low affinities, respectively (n = 3), and α1B adrenoceptors the Kd value was 0,34 nM (n = 3), in agreement with literature (SHIBATA and cols., Mol. Pharmacol., 48:250-258, 1995).\n5. The competition curve was biphasic in preparation of rabbit liver, approximately 2/3 of the sites labeled by 0.1 nM [3H]-prazosin showing high affinity for prazosin (CI50 = 0.16 nM) and 1 / 3 had low affinity sites (CI50 1 nM).\n6. Table 1: ... LDT5 b-7,12 ± 0,22-5,85 ± 0,1518,5 ± 2,5-9,23 ± 0,06 *0,5766 aNDNDNDNDND\n7. Table 2: ... LDT66-6,78 ± 0,08-5,29 ± 0,0732-8,78 ± 0,06a1,664\n8. Table 3: ... LDT24-7,72 ± 0,261,57 x 10-834-8,25 ± 0,674,63 x 10-943-7,97 ± 0,798,81 x 10-953-8,35 ± 0,203,67 x 10-963-8,58 ± 0,342,16 x 10-984-8,34 ± 0,713,76 x 10-9\n9. Table 5: ... LDTα 1A (n)α 1B (n)log IC50 (M)Ki (nM)log IC50 (M)Ki (nM)62-6,51 ± 0,2261 (4)-6,27 ± 0,05448 (3)\n10. Table 6: ... LDT65-5,60 ± 0,061,5(5)66-5,92 ± 0,060,8(5)67-6,10 ± 0,060,5(5)68-6,01 ± 0,030,6(5)\n11. Table 7: ... LDTnlog CI50 ± EPM (M) aKi (M) b24-8,52 ± 0,03 **1,24 x 10-934-8,56 ± 0,07 **1,13 x 10-944-8,62 ± 0,13 **9,88 x 10-1054-8,21 ± 0,05**2,54 x 10-964-9,23 ± 0,24 *2,42 x 10-1083-10,24 ± 0,712,37 x 10-112452-8,03 ± 0,053,80 x 10-9\n12. Table 8: ... LDT5-HT1A (n)log IC50 (M)Ki (nM)62-6,47 ± 0,10147 (3)63-6,37 ± 0,03191 (3)64-6,72 ± 0,1984 (3)65-7,42 ± 0,09c18 (3)\n13. Table 10: ... LDTnlog CI50 ± EPM (M) aKi (M) b23-7,13 ± 0,114,74 x 10-833-7,15 ± 0,224,52 x 10-843-7,16 ± 0,064,42 x 10-853-6,41 ± 0,022,48 x 10-763-6,23 ± 0,463,76 x 10-783-6,41 ± 0,702,48 x 10-7\n14. Table 11: ... 5-HT2A (n)LDTlog IC50 (M)Ki (nM)62-5,00 ± 0,166,41 (3)63-4,86 ± 0,138,85 (4)64-5,06 ± 0,095,58 (3)65-5,34 ± 0,092,93 (4)\n\nNote that some of these sentences are from tables, and the formatting may not be perfect. Let me know if you'd like me to help with anything else!"
    },
    {
        "molecule_name": "[3H]-prazosin",
        "protein_target_name": "α1A adrenoceptors",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "Kd",
        "value": "0.46",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences with specific molecule names, bioactivity metrics, numeric values, and units:\n\n1. We conducted experiments with BMY7378 50 nM, α1D adrenoceptor antagonist used as positive control, and obtained a value of KB = 2.95 nM, consistent with the literature (CARROLL et al, Bioorg Med Chem Lett, 11:1119 - 1121, 2001).\n2. Compared with BMY7378 (KB=2.95 nM) affinity for this receptor is greater for the LDT derivative 5 and 8 (KB = 0.57 and 0.16, respectively, * P &lt;0.05).\n3. For the calculation of the Ki of the LTD's it was used the Cheng-Prusoff equation, where for prazosin (PZS) Kd values were 0.46 nM and 56.5 nM for sites of high and low affinity, respectively to α1A adrenoceptor, and it was used Kd = 0.34 nM for α1B-adrenoceptor.\n4. Kd values of [3H]-prazosin to α1A adrenoceptors were 0.46 nM and 56.5 nM for sites with high and low affinities, respectively (n = 3), and α1B adrenoceptors the Kd value was 0,34 nM (n = 3), in agreement with literature (SHIBATA and cols., Mol. Pharmacol., 48:250-258, 1995).\n5. The competition curve was biphasic in preparation of rabbit liver, approximately 2/3 of the sites labeled by 0.1 nM [3H]-prazosin showing high affinity for prazosin (CI50 = 0.16 nM) and 1 / 3 had low affinity sites (CI50 1 nM).\n6. Table 1: ... LDT5 b-7,12 ± 0,22-5,85 ± 0,1518,5 ± 2,5-9,23 ± 0,06 *0,5766 aNDNDNDNDND\n7. Table 2: ... LDT66-6,78 ± 0,08-5,29 ± 0,0732-8,78 ± 0,06a1,664\n8. Table 3: ... LDT24-7,72 ± 0,261,57 x 10-834-8,25 ± 0,674,63 x 10-943-7,97 ± 0,798,81 x 10-953-8,35 ± 0,203,67 x 10-963-8,58 ± 0,342,16 x 10-984-8,34 ± 0,713,76 x 10-9\n9. Table 5: ... LDTα 1A (n)α 1B (n)log IC50 (M)Ki (nM)log IC50 (M)Ki (nM)62-6,51 ± 0,2261 (4)-6,27 ± 0,05448 (3)\n10. Table 6: ... LDT65-5,60 ± 0,061,5(5)66-5,92 ± 0,060,8(5)67-6,10 ± 0,060,5(5)68-6,01 ± 0,030,6(5)\n11. Table 7: ... LDTnlog CI50 ± EPM (M) aKi (M) b24-8,52 ± 0,03 **1,24 x 10-934-8,56 ± 0,07 **1,13 x 10-944-8,62 ± 0,13 **9,88 x 10-1054-8,21 ± 0,05**2,54 x 10-964-9,23 ± 0,24 *2,42 x 10-1083-10,24 ± 0,712,37 x 10-112452-8,03 ± 0,053,80 x 10-9\n12. Table 8: ... LDT5-HT1A (n)log IC50 (M)Ki (nM)62-6,47 ± 0,10147 (3)63-6,37 ± 0,03191 (3)64-6,72 ± 0,1984 (3)65-7,42 ± 0,09c18 (3)\n13. Table 10: ... LDTnlog CI50 ± EPM (M) aKi (M) b23-7,13 ± 0,114,74 x 10-833-7,15 ± 0,224,52 x 10-843-7,16 ± 0,064,42 x 10-853-6,41 ± 0,022,48 x 10-763-6,23 ± 0,463,76 x 10-783-6,41 ± 0,702,48 x 10-7\n14. Table 11: ... 5-HT2A (n)LDTlog IC50 (M)Ki (nM)62-5,00 ± 0,166,41 (3)63-4,86 ± 0,138,85 (4)64-5,06 ± 0,095,58 (3)65-5,34 ± 0,092,93 (4)\n\nNote that some of these sentences are from tables, and the formatting may not be perfect. Let me know if you'd like me to help with anything else!"
    },
    {
        "molecule_name": "[3H]-prazosin",
        "protein_target_name": "α1A adrenoceptors",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "Kd",
        "value": "56.5",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences with specific molecule names, bioactivity metrics, numeric values, and units:\n\n1. We conducted experiments with BMY7378 50 nM, α1D adrenoceptor antagonist used as positive control, and obtained a value of KB = 2.95 nM, consistent with the literature (CARROLL et al, Bioorg Med Chem Lett, 11:1119 - 1121, 2001).\n2. Compared with BMY7378 (KB=2.95 nM) affinity for this receptor is greater for the LDT derivative 5 and 8 (KB = 0.57 and 0.16, respectively, * P &lt;0.05).\n3. For the calculation of the Ki of the LTD's it was used the Cheng-Prusoff equation, where for prazosin (PZS) Kd values were 0.46 nM and 56.5 nM for sites of high and low affinity, respectively to α1A adrenoceptor, and it was used Kd = 0.34 nM for α1B-adrenoceptor.\n4. Kd values of [3H]-prazosin to α1A adrenoceptors were 0.46 nM and 56.5 nM for sites with high and low affinities, respectively (n = 3), and α1B adrenoceptors the Kd value was 0,34 nM (n = 3), in agreement with literature (SHIBATA and cols., Mol. Pharmacol., 48:250-258, 1995).\n5. The competition curve was biphasic in preparation of rabbit liver, approximately 2/3 of the sites labeled by 0.1 nM [3H]-prazosin showing high affinity for prazosin (CI50 = 0.16 nM) and 1 / 3 had low affinity sites (CI50 1 nM).\n6. Table 1: ... LDT5 b-7,12 ± 0,22-5,85 ± 0,1518,5 ± 2,5-9,23 ± 0,06 *0,5766 aNDNDNDNDND\n7. Table 2: ... LDT66-6,78 ± 0,08-5,29 ± 0,0732-8,78 ± 0,06a1,664\n8. Table 3: ... LDT24-7,72 ± 0,261,57 x 10-834-8,25 ± 0,674,63 x 10-943-7,97 ± 0,798,81 x 10-953-8,35 ± 0,203,67 x 10-963-8,58 ± 0,342,16 x 10-984-8,34 ± 0,713,76 x 10-9\n9. Table 5: ... LDTα 1A (n)α 1B (n)log IC50 (M)Ki (nM)log IC50 (M)Ki (nM)62-6,51 ± 0,2261 (4)-6,27 ± 0,05448 (3)\n10. Table 6: ... LDT65-5,60 ± 0,061,5(5)66-5,92 ± 0,060,8(5)67-6,10 ± 0,060,5(5)68-6,01 ± 0,030,6(5)\n11. Table 7: ... LDTnlog CI50 ± EPM (M) aKi (M) b24-8,52 ± 0,03 **1,24 x 10-934-8,56 ± 0,07 **1,13 x 10-944-8,62 ± 0,13 **9,88 x 10-1054-8,21 ± 0,05**2,54 x 10-964-9,23 ± 0,24 *2,42 x 10-1083-10,24 ± 0,712,37 x 10-112452-8,03 ± 0,053,80 x 10-9\n12. Table 8: ... LDT5-HT1A (n)log IC50 (M)Ki (nM)62-6,47 ± 0,10147 (3)63-6,37 ± 0,03191 (3)64-6,72 ± 0,1984 (3)65-7,42 ± 0,09c18 (3)\n13. Table 10: ... LDTnlog CI50 ± EPM (M) aKi (M) b23-7,13 ± 0,114,74 x 10-833-7,15 ± 0,224,52 x 10-843-7,16 ± 0,064,42 x 10-853-6,41 ± 0,022,48 x 10-763-6,23 ± 0,463,76 x 10-783-6,41 ± 0,702,48 x 10-7\n14. Table 11: ... 5-HT2A (n)LDTlog IC50 (M)Ki (nM)62-5,00 ± 0,166,41 (3)63-4,86 ± 0,138,85 (4)64-5,06 ± 0,095,58 (3)65-5,34 ± 0,092,93 (4)\n\nNote that some of these sentences are from tables, and the formatting may not be perfect. Let me know if you'd like me to help with anything else!"
    },
    {
        "molecule_name": "[3H]-prazosin",
        "protein_target_name": "α1B adrenoceptors",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "Kd",
        "value": "0.34",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences with specific molecule names, bioactivity metrics, numeric values, and units:\n\n1. We conducted experiments with BMY7378 50 nM, α1D adrenoceptor antagonist used as positive control, and obtained a value of KB = 2.95 nM, consistent with the literature (CARROLL et al, Bioorg Med Chem Lett, 11:1119 - 1121, 2001).\n2. Compared with BMY7378 (KB=2.95 nM) affinity for this receptor is greater for the LDT derivative 5 and 8 (KB = 0.57 and 0.16, respectively, * P &lt;0.05).\n3. For the calculation of the Ki of the LTD's it was used the Cheng-Prusoff equation, where for prazosin (PZS) Kd values were 0.46 nM and 56.5 nM for sites of high and low affinity, respectively to α1A adrenoceptor, and it was used Kd = 0.34 nM for α1B-adrenoceptor.\n4. Kd values of [3H]-prazosin to α1A adrenoceptors were 0.46 nM and 56.5 nM for sites with high and low affinities, respectively (n = 3), and α1B adrenoceptors the Kd value was 0,34 nM (n = 3), in agreement with literature (SHIBATA and cols., Mol. Pharmacol., 48:250-258, 1995).\n5. The competition curve was biphasic in preparation of rabbit liver, approximately 2/3 of the sites labeled by 0.1 nM [3H]-prazosin showing high affinity for prazosin (CI50 = 0.16 nM) and 1 / 3 had low affinity sites (CI50 1 nM).\n6. Table 1: ... LDT5 b-7,12 ± 0,22-5,85 ± 0,1518,5 ± 2,5-9,23 ± 0,06 *0,5766 aNDNDNDNDND\n7. Table 2: ... LDT66-6,78 ± 0,08-5,29 ± 0,0732-8,78 ± 0,06a1,664\n8. Table 3: ... LDT24-7,72 ± 0,261,57 x 10-834-8,25 ± 0,674,63 x 10-943-7,97 ± 0,798,81 x 10-953-8,35 ± 0,203,67 x 10-963-8,58 ± 0,342,16 x 10-984-8,34 ± 0,713,76 x 10-9\n9. Table 5: ... LDTα 1A (n)α 1B (n)log IC50 (M)Ki (nM)log IC50 (M)Ki (nM)62-6,51 ± 0,2261 (4)-6,27 ± 0,05448 (3)\n10. Table 6: ... LDT65-5,60 ± 0,061,5(5)66-5,92 ± 0,060,8(5)67-6,10 ± 0,060,5(5)68-6,01 ± 0,030,6(5)\n11. Table 7: ... LDTnlog CI50 ± EPM (M) aKi (M) b24-8,52 ± 0,03 **1,24 x 10-934-8,56 ± 0,07 **1,13 x 10-944-8,62 ± 0,13 **9,88 x 10-1054-8,21 ± 0,05**2,54 x 10-964-9,23 ± 0,24 *2,42 x 10-1083-10,24 ± 0,712,37 x 10-112452-8,03 ± 0,053,80 x 10-9\n12. Table 8: ... LDT5-HT1A (n)log IC50 (M)Ki (nM)62-6,47 ± 0,10147 (3)63-6,37 ± 0,03191 (3)64-6,72 ± 0,1984 (3)65-7,42 ± 0,09c18 (3)\n13. Table 10: ... LDTnlog CI50 ± EPM (M) aKi (M) b23-7,13 ± 0,114,74 x 10-833-7,15 ± 0,224,52 x 10-843-7,16 ± 0,064,42 x 10-853-6,41 ± 0,022,48 x 10-763-6,23 ± 0,463,76 x 10-783-6,41 ± 0,702,48 x 10-7\n14. Table 11: ... 5-HT2A (n)LDTlog IC50 (M)Ki (nM)62-5,00 ± 0,166,41 (3)63-4,86 ± 0,138,85 (4)64-5,06 ± 0,095,58 (3)65-5,34 ± 0,092,93 (4)\n\nNote that some of these sentences are from tables, and the formatting may not be perfect. Let me know if you'd like me to help with anything else!"
    },
    {
        "molecule_name": "LDTα",
        "protein_target_name": "α 1A",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "log IC50",
        "value": "-6.51",
        "unit": "M",
        "raw_mentions": "Here are the extracted sentences with specific molecule names, bioactivity metrics, numeric values, and units:\n\n1. We conducted experiments with BMY7378 50 nM, α1D adrenoceptor antagonist used as positive control, and obtained a value of KB = 2.95 nM, consistent with the literature (CARROLL et al, Bioorg Med Chem Lett, 11:1119 - 1121, 2001).\n2. Compared with BMY7378 (KB=2.95 nM) affinity for this receptor is greater for the LDT derivative 5 and 8 (KB = 0.57 and 0.16, respectively, * P &lt;0.05).\n3. For the calculation of the Ki of the LTD's it was used the Cheng-Prusoff equation, where for prazosin (PZS) Kd values were 0.46 nM and 56.5 nM for sites of high and low affinity, respectively to α1A adrenoceptor, and it was used Kd = 0.34 nM for α1B-adrenoceptor.\n4. Kd values of [3H]-prazosin to α1A adrenoceptors were 0.46 nM and 56.5 nM for sites with high and low affinities, respectively (n = 3), and α1B adrenoceptors the Kd value was 0,34 nM (n = 3), in agreement with literature (SHIBATA and cols., Mol. Pharmacol., 48:250-258, 1995).\n5. The competition curve was biphasic in preparation of rabbit liver, approximately 2/3 of the sites labeled by 0.1 nM [3H]-prazosin showing high affinity for prazosin (CI50 = 0.16 nM) and 1 / 3 had low affinity sites (CI50 1 nM).\n6. Table 1: ... LDT5 b-7,12 ± 0,22-5,85 ± 0,1518,5 ± 2,5-9,23 ± 0,06 *0,5766 aNDNDNDNDND\n7. Table 2: ... LDT66-6,78 ± 0,08-5,29 ± 0,0732-8,78 ± 0,06a1,664\n8. Table 3: ... LDT24-7,72 ± 0,261,57 x 10-834-8,25 ± 0,674,63 x 10-943-7,97 ± 0,798,81 x 10-953-8,35 ± 0,203,67 x 10-963-8,58 ± 0,342,16 x 10-984-8,34 ± 0,713,76 x 10-9\n9. Table 5: ... LDTα 1A (n)α 1B (n)log IC50 (M)Ki (nM)log IC50 (M)Ki (nM)62-6,51 ± 0,2261 (4)-6,27 ± 0,05448 (3)\n10. Table 6: ... LDT65-5,60 ± 0,061,5(5)66-5,92 ± 0,060,8(5)67-6,10 ± 0,060,5(5)68-6,01 ± 0,030,6(5)\n11. Table 7: ... LDTnlog CI50 ± EPM (M) aKi (M) b24-8,52 ± 0,03 **1,24 x 10-934-8,56 ± 0,07 **1,13 x 10-944-8,62 ± 0,13 **9,88 x 10-1054-8,21 ± 0,05**2,54 x 10-964-9,23 ± 0,24 *2,42 x 10-1083-10,24 ± 0,712,37 x 10-112452-8,03 ± 0,053,80 x 10-9\n12. Table 8: ... LDT5-HT1A (n)log IC50 (M)Ki (nM)62-6,47 ± 0,10147 (3)63-6,37 ± 0,03191 (3)64-6,72 ± 0,1984 (3)65-7,42 ± 0,09c18 (3)\n13. Table 10: ... LDTnlog CI50 ± EPM (M) aKi (M) b23-7,13 ± 0,114,74 x 10-833-7,15 ± 0,224,52 x 10-843-7,16 ± 0,064,42 x 10-853-6,41 ± 0,022,48 x 10-763-6,23 ± 0,463,76 x 10-783-6,41 ± 0,702,48 x 10-7\n14. Table 11: ... 5-HT2A (n)LDTlog IC50 (M)Ki (nM)62-5,00 ± 0,166,41 (3)63-4,86 ± 0,138,85 (4)64-5,06 ± 0,095,58 (3)65-5,34 ± 0,092,93 (4)\n\nNote that some of these sentences are from tables, and the formatting may not be perfect. Let me know if you'd like me to help with anything else!"
    },
    {
        "molecule_name": "LDTα",
        "protein_target_name": "α 1A",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "Ki",
        "value": "61",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences with specific molecule names, bioactivity metrics, numeric values, and units:\n\n1. We conducted experiments with BMY7378 50 nM, α1D adrenoceptor antagonist used as positive control, and obtained a value of KB = 2.95 nM, consistent with the literature (CARROLL et al, Bioorg Med Chem Lett, 11:1119 - 1121, 2001).\n2. Compared with BMY7378 (KB=2.95 nM) affinity for this receptor is greater for the LDT derivative 5 and 8 (KB = 0.57 and 0.16, respectively, * P &lt;0.05).\n3. For the calculation of the Ki of the LTD's it was used the Cheng-Prusoff equation, where for prazosin (PZS) Kd values were 0.46 nM and 56.5 nM for sites of high and low affinity, respectively to α1A adrenoceptor, and it was used Kd = 0.34 nM for α1B-adrenoceptor.\n4. Kd values of [3H]-prazosin to α1A adrenoceptors were 0.46 nM and 56.5 nM for sites with high and low affinities, respectively (n = 3), and α1B adrenoceptors the Kd value was 0,34 nM (n = 3), in agreement with literature (SHIBATA and cols., Mol. Pharmacol., 48:250-258, 1995).\n5. The competition curve was biphasic in preparation of rabbit liver, approximately 2/3 of the sites labeled by 0.1 nM [3H]-prazosin showing high affinity for prazosin (CI50 = 0.16 nM) and 1 / 3 had low affinity sites (CI50 1 nM).\n6. Table 1: ... LDT5 b-7,12 ± 0,22-5,85 ± 0,1518,5 ± 2,5-9,23 ± 0,06 *0,5766 aNDNDNDNDND\n7. Table 2: ... LDT66-6,78 ± 0,08-5,29 ± 0,0732-8,78 ± 0,06a1,664\n8. Table 3: ... LDT24-7,72 ± 0,261,57 x 10-834-8,25 ± 0,674,63 x 10-943-7,97 ± 0,798,81 x 10-953-8,35 ± 0,203,67 x 10-963-8,58 ± 0,342,16 x 10-984-8,34 ± 0,713,76 x 10-9\n9. Table 5: ... LDTα 1A (n)α 1B (n)log IC50 (M)Ki (nM)log IC50 (M)Ki (nM)62-6,51 ± 0,2261 (4)-6,27 ± 0,05448 (3)\n10. Table 6: ... LDT65-5,60 ± 0,061,5(5)66-5,92 ± 0,060,8(5)67-6,10 ± 0,060,5(5)68-6,01 ± 0,030,6(5)\n11. Table 7: ... LDTnlog CI50 ± EPM (M) aKi (M) b24-8,52 ± 0,03 **1,24 x 10-934-8,56 ± 0,07 **1,13 x 10-944-8,62 ± 0,13 **9,88 x 10-1054-8,21 ± 0,05**2,54 x 10-964-9,23 ± 0,24 *2,42 x 10-1083-10,24 ± 0,712,37 x 10-112452-8,03 ± 0,053,80 x 10-9\n12. Table 8: ... LDT5-HT1A (n)log IC50 (M)Ki (nM)62-6,47 ± 0,10147 (3)63-6,37 ± 0,03191 (3)64-6,72 ± 0,1984 (3)65-7,42 ± 0,09c18 (3)\n13. Table 10: ... LDTnlog CI50 ± EPM (M) aKi (M) b23-7,13 ± 0,114,74 x 10-833-7,15 ± 0,224,52 x 10-843-7,16 ± 0,064,42 x 10-853-6,41 ± 0,022,48 x 10-763-6,23 ± 0,463,76 x 10-783-6,41 ± 0,702,48 x 10-7\n14. Table 11: ... 5-HT2A (n)LDTlog IC50 (M)Ki (nM)62-5,00 ± 0,166,41 (3)63-4,86 ± 0,138,85 (4)64-5,06 ± 0,095,58 (3)65-5,34 ± 0,092,93 (4)\n\nNote that some of these sentences are from tables, and the formatting may not be perfect. Let me know if you'd like me to help with anything else!"
    },
    {
        "molecule_name": "LDTα",
        "protein_target_name": "α 1B",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "log IC50",
        "value": "-6.27",
        "unit": "M",
        "raw_mentions": "Here are the extracted sentences with specific molecule names, bioactivity metrics, numeric values, and units:\n\n1. We conducted experiments with BMY7378 50 nM, α1D adrenoceptor antagonist used as positive control, and obtained a value of KB = 2.95 nM, consistent with the literature (CARROLL et al, Bioorg Med Chem Lett, 11:1119 - 1121, 2001).\n2. Compared with BMY7378 (KB=2.95 nM) affinity for this receptor is greater for the LDT derivative 5 and 8 (KB = 0.57 and 0.16, respectively, * P &lt;0.05).\n3. For the calculation of the Ki of the LTD's it was used the Cheng-Prusoff equation, where for prazosin (PZS) Kd values were 0.46 nM and 56.5 nM for sites of high and low affinity, respectively to α1A adrenoceptor, and it was used Kd = 0.34 nM for α1B-adrenoceptor.\n4. Kd values of [3H]-prazosin to α1A adrenoceptors were 0.46 nM and 56.5 nM for sites with high and low affinities, respectively (n = 3), and α1B adrenoceptors the Kd value was 0,34 nM (n = 3), in agreement with literature (SHIBATA and cols., Mol. Pharmacol., 48:250-258, 1995).\n5. The competition curve was biphasic in preparation of rabbit liver, approximately 2/3 of the sites labeled by 0.1 nM [3H]-prazosin showing high affinity for prazosin (CI50 = 0.16 nM) and 1 / 3 had low affinity sites (CI50 1 nM).\n6. Table 1: ... LDT5 b-7,12 ± 0,22-5,85 ± 0,1518,5 ± 2,5-9,23 ± 0,06 *0,5766 aNDNDNDNDND\n7. Table 2: ... LDT66-6,78 ± 0,08-5,29 ± 0,0732-8,78 ± 0,06a1,664\n8. Table 3: ... LDT24-7,72 ± 0,261,57 x 10-834-8,25 ± 0,674,63 x 10-943-7,97 ± 0,798,81 x 10-953-8,35 ± 0,203,67 x 10-963-8,58 ± 0,342,16 x 10-984-8,34 ± 0,713,76 x 10-9\n9. Table 5: ... LDTα 1A (n)α 1B (n)log IC50 (M)Ki (nM)log IC50 (M)Ki (nM)62-6,51 ± 0,2261 (4)-6,27 ± 0,05448 (3)\n10. Table 6: ... LDT65-5,60 ± 0,061,5(5)66-5,92 ± 0,060,8(5)67-6,10 ± 0,060,5(5)68-6,01 ± 0,030,6(5)\n11. Table 7: ... LDTnlog CI50 ± EPM (M) aKi (M) b24-8,52 ± 0,03 **1,24 x 10-934-8,56 ± 0,07 **1,13 x 10-944-8,62 ± 0,13 **9,88 x 10-1054-8,21 ± 0,05**2,54 x 10-964-9,23 ± 0,24 *2,42 x 10-1083-10,24 ± 0,712,37 x 10-112452-8,03 ± 0,053,80 x 10-9\n12. Table 8: ... LDT5-HT1A (n)log IC50 (M)Ki (nM)62-6,47 ± 0,10147 (3)63-6,37 ± 0,03191 (3)64-6,72 ± 0,1984 (3)65-7,42 ± 0,09c18 (3)\n13. Table 10: ... LDTnlog CI50 ± EPM (M) aKi (M) b23-7,13 ± 0,114,74 x 10-833-7,15 ± 0,224,52 x 10-843-7,16 ± 0,064,42 x 10-853-6,41 ± 0,022,48 x 10-763-6,23 ± 0,463,76 x 10-783-6,41 ± 0,702,48 x 10-7\n14. Table 11: ... 5-HT2A (n)LDTlog IC50 (M)Ki (nM)62-5,00 ± 0,166,41 (3)63-4,86 ± 0,138,85 (4)64-5,06 ± 0,095,58 (3)65-5,34 ± 0,092,93 (4)\n\nNote that some of these sentences are from tables, and the formatting may not be perfect. Let me know if you'd like me to help with anything else!"
    },
    {
        "molecule_name": "LDTα",
        "protein_target_name": "α 1B",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "Ki",
        "value": "5448",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences with specific molecule names, bioactivity metrics, numeric values, and units:\n\n1. We conducted experiments with BMY7378 50 nM, α1D adrenoceptor antagonist used as positive control, and obtained a value of KB = 2.95 nM, consistent with the literature (CARROLL et al, Bioorg Med Chem Lett, 11:1119 - 1121, 2001).\n2. Compared with BMY7378 (KB=2.95 nM) affinity for this receptor is greater for the LDT derivative 5 and 8 (KB = 0.57 and 0.16, respectively, * P &lt;0.05).\n3. For the calculation of the Ki of the LTD's it was used the Cheng-Prusoff equation, where for prazosin (PZS) Kd values were 0.46 nM and 56.5 nM for sites of high and low affinity, respectively to α1A adrenoceptor, and it was used Kd = 0.34 nM for α1B-adrenoceptor.\n4. Kd values of [3H]-prazosin to α1A adrenoceptors were 0.46 nM and 56.5 nM for sites with high and low affinities, respectively (n = 3), and α1B adrenoceptors the Kd value was 0,34 nM (n = 3), in agreement with literature (SHIBATA and cols., Mol. Pharmacol., 48:250-258, 1995).\n5. The competition curve was biphasic in preparation of rabbit liver, approximately 2/3 of the sites labeled by 0.1 nM [3H]-prazosin showing high affinity for prazosin (CI50 = 0.16 nM) and 1 / 3 had low affinity sites (CI50 1 nM).\n6. Table 1: ... LDT5 b-7,12 ± 0,22-5,85 ± 0,1518,5 ± 2,5-9,23 ± 0,06 *0,5766 aNDNDNDNDND\n7. Table 2: ... LDT66-6,78 ± 0,08-5,29 ± 0,0732-8,78 ± 0,06a1,664\n8. Table 3: ... LDT24-7,72 ± 0,261,57 x 10-834-8,25 ± 0,674,63 x 10-943-7,97 ± 0,798,81 x 10-953-8,35 ± 0,203,67 x 10-963-8,58 ± 0,342,16 x 10-984-8,34 ± 0,713,76 x 10-9\n9. Table 5: ... LDTα 1A (n)α 1B (n)log IC50 (M)Ki (nM)log IC50 (M)Ki (nM)62-6,51 ± 0,2261 (4)-6,27 ± 0,05448 (3)\n10. Table 6: ... LDT65-5,60 ± 0,061,5(5)66-5,92 ± 0,060,8(5)67-6,10 ± 0,060,5(5)68-6,01 ± 0,030,6(5)\n11. Table 7: ... LDTnlog CI50 ± EPM (M) aKi (M) b24-8,52 ± 0,03 **1,24 x 10-934-8,56 ± 0,07 **1,13 x 10-944-8,62 ± 0,13 **9,88 x 10-1054-8,21 ± 0,05**2,54 x 10-964-9,23 ± 0,24 *2,42 x 10-1083-10,24 ± 0,712,37 x 10-112452-8,03 ± 0,053,80 x 10-9\n12. Table 8: ... LDT5-HT1A (n)log IC50 (M)Ki (nM)62-6,47 ± 0,10147 (3)63-6,37 ± 0,03191 (3)64-6,72 ± 0,1984 (3)65-7,42 ± 0,09c18 (3)\n13. Table 10: ... LDTnlog CI50 ± EPM (M) aKi (M) b23-7,13 ± 0,114,74 x 10-833-7,15 ± 0,224,52 x 10-843-7,16 ± 0,064,42 x 10-853-6,41 ± 0,022,48 x 10-763-6,23 ± 0,463,76 x 10-783-6,41 ± 0,702,48 x 10-7\n14. Table 11: ... 5-HT2A (n)LDTlog IC50 (M)Ki (nM)62-5,00 ± 0,166,41 (3)63-4,86 ± 0,138,85 (4)64-5,06 ± 0,095,58 (3)65-5,34 ± 0,092,93 (4)\n\nNote that some of these sentences are from tables, and the formatting may not be perfect. Let me know if you'd like me to help with anything else!"
    },
    {
        "molecule_name": "LDT62",
        "protein_target_name": "5-HT1A",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "log IC50",
        "value": "-6.47",
        "unit": "M",
        "raw_mentions": "Here are the extracted sentences with specific molecule names, bioactivity metrics, numeric values, and units:\n\n1. We conducted experiments with BMY7378 50 nM, α1D adrenoceptor antagonist used as positive control, and obtained a value of KB = 2.95 nM, consistent with the literature (CARROLL et al, Bioorg Med Chem Lett, 11:1119 - 1121, 2001).\n2. Compared with BMY7378 (KB=2.95 nM) affinity for this receptor is greater for the LDT derivative 5 and 8 (KB = 0.57 and 0.16, respectively, * P &lt;0.05).\n3. For the calculation of the Ki of the LTD's it was used the Cheng-Prusoff equation, where for prazosin (PZS) Kd values were 0.46 nM and 56.5 nM for sites of high and low affinity, respectively to α1A adrenoceptor, and it was used Kd = 0.34 nM for α1B-adrenoceptor.\n4. Kd values of [3H]-prazosin to α1A adrenoceptors were 0.46 nM and 56.5 nM for sites with high and low affinities, respectively (n = 3), and α1B adrenoceptors the Kd value was 0,34 nM (n = 3), in agreement with literature (SHIBATA and cols., Mol. Pharmacol., 48:250-258, 1995).\n5. The competition curve was biphasic in preparation of rabbit liver, approximately 2/3 of the sites labeled by 0.1 nM [3H]-prazosin showing high affinity for prazosin (CI50 = 0.16 nM) and 1 / 3 had low affinity sites (CI50 1 nM).\n6. Table 1: ... LDT5 b-7,12 ± 0,22-5,85 ± 0,1518,5 ± 2,5-9,23 ± 0,06 *0,5766 aNDNDNDNDND\n7. Table 2: ... LDT66-6,78 ± 0,08-5,29 ± 0,0732-8,78 ± 0,06a1,664\n8. Table 3: ... LDT24-7,72 ± 0,261,57 x 10-834-8,25 ± 0,674,63 x 10-943-7,97 ± 0,798,81 x 10-953-8,35 ± 0,203,67 x 10-963-8,58 ± 0,342,16 x 10-984-8,34 ± 0,713,76 x 10-9\n9. Table 5: ... LDTα 1A (n)α 1B (n)log IC50 (M)Ki (nM)log IC50 (M)Ki (nM)62-6,51 ± 0,2261 (4)-6,27 ± 0,05448 (3)\n10. Table 6: ... LDT65-5,60 ± 0,061,5(5)66-5,92 ± 0,060,8(5)67-6,10 ± 0,060,5(5)68-6,01 ± 0,030,6(5)\n11. Table 7: ... LDTnlog CI50 ± EPM (M) aKi (M) b24-8,52 ± 0,03 **1,24 x 10-934-8,56 ± 0,07 **1,13 x 10-944-8,62 ± 0,13 **9,88 x 10-1054-8,21 ± 0,05**2,54 x 10-964-9,23 ± 0,24 *2,42 x 10-1083-10,24 ± 0,712,37 x 10-112452-8,03 ± 0,053,80 x 10-9\n12. Table 8: ... LDT5-HT1A (n)log IC50 (M)Ki (nM)62-6,47 ± 0,10147 (3)63-6,37 ± 0,03191 (3)64-6,72 ± 0,1984 (3)65-7,42 ± 0,09c18 (3)\n13. Table 10: ... LDTnlog CI50 ± EPM (M) aKi (M) b23-7,13 ± 0,114,74 x 10-833-7,15 ± 0,224,52 x 10-843-7,16 ± 0,064,42 x 10-853-6,41 ± 0,022,48 x 10-763-6,23 ± 0,463,76 x 10-783-6,41 ± 0,702,48 x 10-7\n14. Table 11: ... 5-HT2A (n)LDTlog IC50 (M)Ki (nM)62-5,00 ± 0,166,41 (3)63-4,86 ± 0,138,85 (4)64-5,06 ± 0,095,58 (3)65-5,34 ± 0,092,93 (4)\n\nNote that some of these sentences are from tables, and the formatting may not be perfect. Let me know if you'd like me to help with anything else!"
    },
    {
        "molecule_name": "LDT62",
        "protein_target_name": "5-HT1A",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "Ki",
        "value": "147",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences with specific molecule names, bioactivity metrics, numeric values, and units:\n\n1. We conducted experiments with BMY7378 50 nM, α1D adrenoceptor antagonist used as positive control, and obtained a value of KB = 2.95 nM, consistent with the literature (CARROLL et al, Bioorg Med Chem Lett, 11:1119 - 1121, 2001).\n2. Compared with BMY7378 (KB=2.95 nM) affinity for this receptor is greater for the LDT derivative 5 and 8 (KB = 0.57 and 0.16, respectively, * P &lt;0.05).\n3. For the calculation of the Ki of the LTD's it was used the Cheng-Prusoff equation, where for prazosin (PZS) Kd values were 0.46 nM and 56.5 nM for sites of high and low affinity, respectively to α1A adrenoceptor, and it was used Kd = 0.34 nM for α1B-adrenoceptor.\n4. Kd values of [3H]-prazosin to α1A adrenoceptors were 0.46 nM and 56.5 nM for sites with high and low affinities, respectively (n = 3), and α1B adrenoceptors the Kd value was 0,34 nM (n = 3), in agreement with literature (SHIBATA and cols., Mol. Pharmacol., 48:250-258, 1995).\n5. The competition curve was biphasic in preparation of rabbit liver, approximately 2/3 of the sites labeled by 0.1 nM [3H]-prazosin showing high affinity for prazosin (CI50 = 0.16 nM) and 1 / 3 had low affinity sites (CI50 1 nM).\n6. Table 1: ... LDT5 b-7,12 ± 0,22-5,85 ± 0,1518,5 ± 2,5-9,23 ± 0,06 *0,5766 aNDNDNDNDND\n7. Table 2: ... LDT66-6,78 ± 0,08-5,29 ± 0,0732-8,78 ± 0,06a1,664\n8. Table 3: ... LDT24-7,72 ± 0,261,57 x 10-834-8,25 ± 0,674,63 x 10-943-7,97 ± 0,798,81 x 10-953-8,35 ± 0,203,67 x 10-963-8,58 ± 0,342,16 x 10-984-8,34 ± 0,713,76 x 10-9\n9. Table 5: ... LDTα 1A (n)α 1B (n)log IC50 (M)Ki (nM)log IC50 (M)Ki (nM)62-6,51 ± 0,2261 (4)-6,27 ± 0,05448 (3)\n10. Table 6: ... LDT65-5,60 ± 0,061,5(5)66-5,92 ± 0,060,8(5)67-6,10 ± 0,060,5(5)68-6,01 ± 0,030,6(5)\n11. Table 7: ... LDTnlog CI50 ± EPM (M) aKi (M) b24-8,52 ± 0,03 **1,24 x 10-934-8,56 ± 0,07 **1,13 x 10-944-8,62 ± 0,13 **9,88 x 10-1054-8,21 ± 0,05**2,54 x 10-964-9,23 ± 0,24 *2,42 x 10-1083-10,24 ± 0,712,37 x 10-112452-8,03 ± 0,053,80 x 10-9\n12. Table 8: ... LDT5-HT1A (n)log IC50 (M)Ki (nM)62-6,47 ± 0,10147 (3)63-6,37 ± 0,03191 (3)64-6,72 ± 0,1984 (3)65-7,42 ± 0,09c18 (3)\n13. Table 10: ... LDTnlog CI50 ± EPM (M) aKi (M) b23-7,13 ± 0,114,74 x 10-833-7,15 ± 0,224,52 x 10-843-7,16 ± 0,064,42 x 10-853-6,41 ± 0,022,48 x 10-763-6,23 ± 0,463,76 x 10-783-6,41 ± 0,702,48 x 10-7\n14. Table 11: ... 5-HT2A (n)LDTlog IC50 (M)Ki (nM)62-5,00 ± 0,166,41 (3)63-4,86 ± 0,138,85 (4)64-5,06 ± 0,095,58 (3)65-5,34 ± 0,092,93 (4)\n\nNote that some of these sentences are from tables, and the formatting may not be perfect. Let me know if you'd like me to help with anything else!"
    },
    {
        "molecule_name": "LDT63",
        "protein_target_name": "5-HT1A",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "log IC50",
        "value": "-6.37",
        "unit": "M",
        "raw_mentions": "Here are the extracted sentences with specific molecule names, bioactivity metrics, numeric values, and units:\n\n1. We conducted experiments with BMY7378 50 nM, α1D adrenoceptor antagonist used as positive control, and obtained a value of KB = 2.95 nM, consistent with the literature (CARROLL et al, Bioorg Med Chem Lett, 11:1119 - 1121, 2001).\n2. Compared with BMY7378 (KB=2.95 nM) affinity for this receptor is greater for the LDT derivative 5 and 8 (KB = 0.57 and 0.16, respectively, * P &lt;0.05).\n3. For the calculation of the Ki of the LTD's it was used the Cheng-Prusoff equation, where for prazosin (PZS) Kd values were 0.46 nM and 56.5 nM for sites of high and low affinity, respectively to α1A adrenoceptor, and it was used Kd = 0.34 nM for α1B-adrenoceptor.\n4. Kd values of [3H]-prazosin to α1A adrenoceptors were 0.46 nM and 56.5 nM for sites with high and low affinities, respectively (n = 3), and α1B adrenoceptors the Kd value was 0,34 nM (n = 3), in agreement with literature (SHIBATA and cols., Mol. Pharmacol., 48:250-258, 1995).\n5. The competition curve was biphasic in preparation of rabbit liver, approximately 2/3 of the sites labeled by 0.1 nM [3H]-prazosin showing high affinity for prazosin (CI50 = 0.16 nM) and 1 / 3 had low affinity sites (CI50 1 nM).\n6. Table 1: ... LDT5 b-7,12 ± 0,22-5,85 ± 0,1518,5 ± 2,5-9,23 ± 0,06 *0,5766 aNDNDNDNDND\n7. Table 2: ... LDT66-6,78 ± 0,08-5,29 ± 0,0732-8,78 ± 0,06a1,664\n8. Table 3: ... LDT24-7,72 ± 0,261,57 x 10-834-8,25 ± 0,674,63 x 10-943-7,97 ± 0,798,81 x 10-953-8,35 ± 0,203,67 x 10-963-8,58 ± 0,342,16 x 10-984-8,34 ± 0,713,76 x 10-9\n9. Table 5: ... LDTα 1A (n)α 1B (n)log IC50 (M)Ki (nM)log IC50 (M)Ki (nM)62-6,51 ± 0,2261 (4)-6,27 ± 0,05448 (3)\n10. Table 6: ... LDT65-5,60 ± 0,061,5(5)66-5,92 ± 0,060,8(5)67-6,10 ± 0,060,5(5)68-6,01 ± 0,030,6(5)\n11. Table 7: ... LDTnlog CI50 ± EPM (M) aKi (M) b24-8,52 ± 0,03 **1,24 x 10-934-8,56 ± 0,07 **1,13 x 10-944-8,62 ± 0,13 **9,88 x 10-1054-8,21 ± 0,05**2,54 x 10-964-9,23 ± 0,24 *2,42 x 10-1083-10,24 ± 0,712,37 x 10-112452-8,03 ± 0,053,80 x 10-9\n12. Table 8: ... LDT5-HT1A (n)log IC50 (M)Ki (nM)62-6,47 ± 0,10147 (3)63-6,37 ± 0,03191 (3)64-6,72 ± 0,1984 (3)65-7,42 ± 0,09c18 (3)\n13. Table 10: ... LDTnlog CI50 ± EPM (M) aKi (M) b23-7,13 ± 0,114,74 x 10-833-7,15 ± 0,224,52 x 10-843-7,16 ± 0,064,42 x 10-853-6,41 ± 0,022,48 x 10-763-6,23 ± 0,463,76 x 10-783-6,41 ± 0,702,48 x 10-7\n14. Table 11: ... 5-HT2A (n)LDTlog IC50 (M)Ki (nM)62-5,00 ± 0,166,41 (3)63-4,86 ± 0,138,85 (4)64-5,06 ± 0,095,58 (3)65-5,34 ± 0,092,93 (4)\n\nNote that some of these sentences are from tables, and the formatting may not be perfect. Let me know if you'd like me to help with anything else!"
    },
    {
        "molecule_name": "LDT63",
        "protein_target_name": "5-HT1A",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "Ki",
        "value": "191",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences with specific molecule names, bioactivity metrics, numeric values, and units:\n\n1. We conducted experiments with BMY7378 50 nM, α1D adrenoceptor antagonist used as positive control, and obtained a value of KB = 2.95 nM, consistent with the literature (CARROLL et al, Bioorg Med Chem Lett, 11:1119 - 1121, 2001).\n2. Compared with BMY7378 (KB=2.95 nM) affinity for this receptor is greater for the LDT derivative 5 and 8 (KB = 0.57 and 0.16, respectively, * P &lt;0.05).\n3. For the calculation of the Ki of the LTD's it was used the Cheng-Prusoff equation, where for prazosin (PZS) Kd values were 0.46 nM and 56.5 nM for sites of high and low affinity, respectively to α1A adrenoceptor, and it was used Kd = 0.34 nM for α1B-adrenoceptor.\n4. Kd values of [3H]-prazosin to α1A adrenoceptors were 0.46 nM and 56.5 nM for sites with high and low affinities, respectively (n = 3), and α1B adrenoceptors the Kd value was 0,34 nM (n = 3), in agreement with literature (SHIBATA and cols., Mol. Pharmacol., 48:250-258, 1995).\n5. The competition curve was biphasic in preparation of rabbit liver, approximately 2/3 of the sites labeled by 0.1 nM [3H]-prazosin showing high affinity for prazosin (CI50 = 0.16 nM) and 1 / 3 had low affinity sites (CI50 1 nM).\n6. Table 1: ... LDT5 b-7,12 ± 0,22-5,85 ± 0,1518,5 ± 2,5-9,23 ± 0,06 *0,5766 aNDNDNDNDND\n7. Table 2: ... LDT66-6,78 ± 0,08-5,29 ± 0,0732-8,78 ± 0,06a1,664\n8. Table 3: ... LDT24-7,72 ± 0,261,57 x 10-834-8,25 ± 0,674,63 x 10-943-7,97 ± 0,798,81 x 10-953-8,35 ± 0,203,67 x 10-963-8,58 ± 0,342,16 x 10-984-8,34 ± 0,713,76 x 10-9\n9. Table 5: ... LDTα 1A (n)α 1B (n)log IC50 (M)Ki (nM)log IC50 (M)Ki (nM)62-6,51 ± 0,2261 (4)-6,27 ± 0,05448 (3)\n10. Table 6: ... LDT65-5,60 ± 0,061,5(5)66-5,92 ± 0,060,8(5)67-6,10 ± 0,060,5(5)68-6,01 ± 0,030,6(5)\n11. Table 7: ... LDTnlog CI50 ± EPM (M) aKi (M) b24-8,52 ± 0,03 **1,24 x 10-934-8,56 ± 0,07 **1,13 x 10-944-8,62 ± 0,13 **9,88 x 10-1054-8,21 ± 0,05**2,54 x 10-964-9,23 ± 0,24 *2,42 x 10-1083-10,24 ± 0,712,37 x 10-112452-8,03 ± 0,053,80 x 10-9\n12. Table 8: ... LDT5-HT1A (n)log IC50 (M)Ki (nM)62-6,47 ± 0,10147 (3)63-6,37 ± 0,03191 (3)64-6,72 ± 0,1984 (3)65-7,42 ± 0,09c18 (3)\n13. Table 10: ... LDTnlog CI50 ± EPM (M) aKi (M) b23-7,13 ± 0,114,74 x 10-833-7,15 ± 0,224,52 x 10-843-7,16 ± 0,064,42 x 10-853-6,41 ± 0,022,48 x 10-763-6,23 ± 0,463,76 x 10-783-6,41 ± 0,702,48 x 10-7\n14. Table 11: ... 5-HT2A (n)LDTlog IC50 (M)Ki (nM)62-5,00 ± 0,166,41 (3)63-4,86 ± 0,138,85 (4)64-5,06 ± 0,095,58 (3)65-5,34 ± 0,092,93 (4)\n\nNote that some of these sentences are from tables, and the formatting may not be perfect. Let me know if you'd like me to help with anything else!"
    },
    {
        "molecule_name": "LDT64",
        "protein_target_name": "5-HT1A",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "log IC50",
        "value": "-6.72",
        "unit": "M",
        "raw_mentions": "Here are the extracted sentences with specific molecule names, bioactivity metrics, numeric values, and units:\n\n1. We conducted experiments with BMY7378 50 nM, α1D adrenoceptor antagonist used as positive control, and obtained a value of KB = 2.95 nM, consistent with the literature (CARROLL et al, Bioorg Med Chem Lett, 11:1119 - 1121, 2001).\n2. Compared with BMY7378 (KB=2.95 nM) affinity for this receptor is greater for the LDT derivative 5 and 8 (KB = 0.57 and 0.16, respectively, * P &lt;0.05).\n3. For the calculation of the Ki of the LTD's it was used the Cheng-Prusoff equation, where for prazosin (PZS) Kd values were 0.46 nM and 56.5 nM for sites of high and low affinity, respectively to α1A adrenoceptor, and it was used Kd = 0.34 nM for α1B-adrenoceptor.\n4. Kd values of [3H]-prazosin to α1A adrenoceptors were 0.46 nM and 56.5 nM for sites with high and low affinities, respectively (n = 3), and α1B adrenoceptors the Kd value was 0,34 nM (n = 3), in agreement with literature (SHIBATA and cols., Mol. Pharmacol., 48:250-258, 1995).\n5. The competition curve was biphasic in preparation of rabbit liver, approximately 2/3 of the sites labeled by 0.1 nM [3H]-prazosin showing high affinity for prazosin (CI50 = 0.16 nM) and 1 / 3 had low affinity sites (CI50 1 nM).\n6. Table 1: ... LDT5 b-7,12 ± 0,22-5,85 ± 0,1518,5 ± 2,5-9,23 ± 0,06 *0,5766 aNDNDNDNDND\n7. Table 2: ... LDT66-6,78 ± 0,08-5,29 ± 0,0732-8,78 ± 0,06a1,664\n8. Table 3: ... LDT24-7,72 ± 0,261,57 x 10-834-8,25 ± 0,674,63 x 10-943-7,97 ± 0,798,81 x 10-953-8,35 ± 0,203,67 x 10-963-8,58 ± 0,342,16 x 10-984-8,34 ± 0,713,76 x 10-9\n9. Table 5: ... LDTα 1A (n)α 1B (n)log IC50 (M)Ki (nM)log IC50 (M)Ki (nM)62-6,51 ± 0,2261 (4)-6,27 ± 0,05448 (3)\n10. Table 6: ... LDT65-5,60 ± 0,061,5(5)66-5,92 ± 0,060,8(5)67-6,10 ± 0,060,5(5)68-6,01 ± 0,030,6(5)\n11. Table 7: ... LDTnlog CI50 ± EPM (M) aKi (M) b24-8,52 ± 0,03 **1,24 x 10-934-8,56 ± 0,07 **1,13 x 10-944-8,62 ± 0,13 **9,88 x 10-1054-8,21 ± 0,05**2,54 x 10-964-9,23 ± 0,24 *2,42 x 10-1083-10,24 ± 0,712,37 x 10-112452-8,03 ± 0,053,80 x 10-9\n12. Table 8: ... LDT5-HT1A (n)log IC50 (M)Ki (nM)62-6,47 ± 0,10147 (3)63-6,37 ± 0,03191 (3)64-6,72 ± 0,1984 (3)65-7,42 ± 0,09c18 (3)\n13. Table 10: ... LDTnlog CI50 ± EPM (M) aKi (M) b23-7,13 ± 0,114,74 x 10-833-7,15 ± 0,224,52 x 10-843-7,16 ± 0,064,42 x 10-853-6,41 ± 0,022,48 x 10-763-6,23 ± 0,463,76 x 10-783-6,41 ± 0,702,48 x 10-7\n14. Table 11: ... 5-HT2A (n)LDTlog IC50 (M)Ki (nM)62-5,00 ± 0,166,41 (3)63-4,86 ± 0,138,85 (4)64-5,06 ± 0,095,58 (3)65-5,34 ± 0,092,93 (4)\n\nNote that some of these sentences are from tables, and the formatting may not be perfect. Let me know if you'd like me to help with anything else!"
    },
    {
        "molecule_name": "LDT64",
        "protein_target_name": "5-HT1A",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "Ki",
        "value": "84",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences with specific molecule names, bioactivity metrics, numeric values, and units:\n\n1. We conducted experiments with BMY7378 50 nM, α1D adrenoceptor antagonist used as positive control, and obtained a value of KB = 2.95 nM, consistent with the literature (CARROLL et al, Bioorg Med Chem Lett, 11:1119 - 1121, 2001).\n2. Compared with BMY7378 (KB=2.95 nM) affinity for this receptor is greater for the LDT derivative 5 and 8 (KB = 0.57 and 0.16, respectively, * P &lt;0.05).\n3. For the calculation of the Ki of the LTD's it was used the Cheng-Prusoff equation, where for prazosin (PZS) Kd values were 0.46 nM and 56.5 nM for sites of high and low affinity, respectively to α1A adrenoceptor, and it was used Kd = 0.34 nM for α1B-adrenoceptor.\n4. Kd values of [3H]-prazosin to α1A adrenoceptors were 0.46 nM and 56.5 nM for sites with high and low affinities, respectively (n = 3), and α1B adrenoceptors the Kd value was 0,34 nM (n = 3), in agreement with literature (SHIBATA and cols., Mol. Pharmacol., 48:250-258, 1995).\n5. The competition curve was biphasic in preparation of rabbit liver, approximately 2/3 of the sites labeled by 0.1 nM [3H]-prazosin showing high affinity for prazosin (CI50 = 0.16 nM) and 1 / 3 had low affinity sites (CI50 1 nM).\n6. Table 1: ... LDT5 b-7,12 ± 0,22-5,85 ± 0,1518,5 ± 2,5-9,23 ± 0,06 *0,5766 aNDNDNDNDND\n7. Table 2: ... LDT66-6,78 ± 0,08-5,29 ± 0,0732-8,78 ± 0,06a1,664\n8. Table 3: ... LDT24-7,72 ± 0,261,57 x 10-834-8,25 ± 0,674,63 x 10-943-7,97 ± 0,798,81 x 10-953-8,35 ± 0,203,67 x 10-963-8,58 ± 0,342,16 x 10-984-8,34 ± 0,713,76 x 10-9\n9. Table 5: ... LDTα 1A (n)α 1B (n)log IC50 (M)Ki (nM)log IC50 (M)Ki (nM)62-6,51 ± 0,2261 (4)-6,27 ± 0,05448 (3)\n10. Table 6: ... LDT65-5,60 ± 0,061,5(5)66-5,92 ± 0,060,8(5)67-6,10 ± 0,060,5(5)68-6,01 ± 0,030,6(5)\n11. Table 7: ... LDTnlog CI50 ± EPM (M) aKi (M) b24-8,52 ± 0,03 **1,24 x 10-934-8,56 ± 0,07 **1,13 x 10-944-8,62 ± 0,13 **9,88 x 10-1054-8,21 ± 0,05**2,54 x 10-964-9,23 ± 0,24 *2,42 x 10-1083-10,24 ± 0,712,37 x 10-112452-8,03 ± 0,053,80 x 10-9\n12. Table 8: ... LDT5-HT1A (n)log IC50 (M)Ki (nM)62-6,47 ± 0,10147 (3)63-6,37 ± 0,03191 (3)64-6,72 ± 0,1984 (3)65-7,42 ± 0,09c18 (3)\n13. Table 10: ... LDTnlog CI50 ± EPM (M) aKi (M) b23-7,13 ± 0,114,74 x 10-833-7,15 ± 0,224,52 x 10-843-7,16 ± 0,064,42 x 10-853-6,41 ± 0,022,48 x 10-763-6,23 ± 0,463,76 x 10-783-6,41 ± 0,702,48 x 10-7\n14. Table 11: ... 5-HT2A (n)LDTlog IC50 (M)Ki (nM)62-5,00 ± 0,166,41 (3)63-4,86 ± 0,138,85 (4)64-5,06 ± 0,095,58 (3)65-5,34 ± 0,092,93 (4)\n\nNote that some of these sentences are from tables, and the formatting may not be perfect. Let me know if you'd like me to help with anything else!"
    },
    {
        "molecule_name": "LDT65",
        "protein_target_name": "5-HT1A",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "log IC50",
        "value": "-7.42",
        "unit": "M",
        "raw_mentions": "Here are the extracted sentences with specific molecule names, bioactivity metrics, numeric values, and units:\n\n1. We conducted experiments with BMY7378 50 nM, α1D adrenoceptor antagonist used as positive control, and obtained a value of KB = 2.95 nM, consistent with the literature (CARROLL et al, Bioorg Med Chem Lett, 11:1119 - 1121, 2001).\n2. Compared with BMY7378 (KB=2.95 nM) affinity for this receptor is greater for the LDT derivative 5 and 8 (KB = 0.57 and 0.16, respectively, * P &lt;0.05).\n3. For the calculation of the Ki of the LTD's it was used the Cheng-Prusoff equation, where for prazosin (PZS) Kd values were 0.46 nM and 56.5 nM for sites of high and low affinity, respectively to α1A adrenoceptor, and it was used Kd = 0.34 nM for α1B-adrenoceptor.\n4. Kd values of [3H]-prazosin to α1A adrenoceptors were 0.46 nM and 56.5 nM for sites with high and low affinities, respectively (n = 3), and α1B adrenoceptors the Kd value was 0,34 nM (n = 3), in agreement with literature (SHIBATA and cols., Mol. Pharmacol., 48:250-258, 1995).\n5. The competition curve was biphasic in preparation of rabbit liver, approximately 2/3 of the sites labeled by 0.1 nM [3H]-prazosin showing high affinity for prazosin (CI50 = 0.16 nM) and 1 / 3 had low affinity sites (CI50 1 nM).\n6. Table 1: ... LDT5 b-7,12 ± 0,22-5,85 ± 0,1518,5 ± 2,5-9,23 ± 0,06 *0,5766 aNDNDNDNDND\n7. Table 2: ... LDT66-6,78 ± 0,08-5,29 ± 0,0732-8,78 ± 0,06a1,664\n8. Table 3: ... LDT24-7,72 ± 0,261,57 x 10-834-8,25 ± 0,674,63 x 10-943-7,97 ± 0,798,81 x 10-953-8,35 ± 0,203,67 x 10-963-8,58 ± 0,342,16 x 10-984-8,34 ± 0,713,76 x 10-9\n9. Table 5: ... LDTα 1A (n)α 1B (n)log IC50 (M)Ki (nM)log IC50 (M)Ki (nM)62-6,51 ± 0,2261 (4)-6,27 ± 0,05448 (3)\n10. Table 6: ... LDT65-5,60 ± 0,061,5(5)66-5,92 ± 0,060,8(5)67-6,10 ± 0,060,5(5)68-6,01 ± 0,030,6(5)\n11. Table 7: ... LDTnlog CI50 ± EPM (M) aKi (M) b24-8,52 ± 0,03 **1,24 x 10-934-8,56 ± 0,07 **1,13 x 10-944-8,62 ± 0,13 **9,88 x 10-1054-8,21 ± 0,05**2,54 x 10-964-9,23 ± 0,24 *2,42 x 10-1083-10,24 ± 0,712,37 x 10-112452-8,03 ± 0,053,80 x 10-9\n12. Table 8: ... LDT5-HT1A (n)log IC50 (M)Ki (nM)62-6,47 ± 0,10147 (3)63-6,37 ± 0,03191 (3)64-6,72 ± 0,1984 (3)65-7,42 ± 0,09c18 (3)\n13. Table 10: ... LDTnlog CI50 ± EPM (M) aKi (M) b23-7,13 ± 0,114,74 x 10-833-7,15 ± 0,224,52 x 10-843-7,16 ± 0,064,42 x 10-853-6,41 ± 0,022,48 x 10-763-6,23 ± 0,463,76 x 10-783-6,41 ± 0,702,48 x 10-7\n14. Table 11: ... 5-HT2A (n)LDTlog IC50 (M)Ki (nM)62-5,00 ± 0,166,41 (3)63-4,86 ± 0,138,85 (4)64-5,06 ± 0,095,58 (3)65-5,34 ± 0,092,93 (4)\n\nNote that some of these sentences are from tables, and the formatting may not be perfect. Let me know if you'd like me to help with anything else!"
    },
    {
        "molecule_name": "LDT65",
        "protein_target_name": "5-HT1A",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "Ki",
        "value": "18",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences with specific molecule names, bioactivity metrics, numeric values, and units:\n\n1. We conducted experiments with BMY7378 50 nM, α1D adrenoceptor antagonist used as positive control, and obtained a value of KB = 2.95 nM, consistent with the literature (CARROLL et al, Bioorg Med Chem Lett, 11:1119 - 1121, 2001).\n2. Compared with BMY7378 (KB=2.95 nM) affinity for this receptor is greater for the LDT derivative 5 and 8 (KB = 0.57 and 0.16, respectively, * P &lt;0.05).\n3. For the calculation of the Ki of the LTD's it was used the Cheng-Prusoff equation, where for prazosin (PZS) Kd values were 0.46 nM and 56.5 nM for sites of high and low affinity, respectively to α1A adrenoceptor, and it was used Kd = 0.34 nM for α1B-adrenoceptor.\n4. Kd values of [3H]-prazosin to α1A adrenoceptors were 0.46 nM and 56.5 nM for sites with high and low affinities, respectively (n = 3), and α1B adrenoceptors the Kd value was 0,34 nM (n = 3), in agreement with literature (SHIBATA and cols., Mol. Pharmacol., 48:250-258, 1995).\n5. The competition curve was biphasic in preparation of rabbit liver, approximately 2/3 of the sites labeled by 0.1 nM [3H]-prazosin showing high affinity for prazosin (CI50 = 0.16 nM) and 1 / 3 had low affinity sites (CI50 1 nM).\n6. Table 1: ... LDT5 b-7,12 ± 0,22-5,85 ± 0,1518,5 ± 2,5-9,23 ± 0,06 *0,5766 aNDNDNDNDND\n7. Table 2: ... LDT66-6,78 ± 0,08-5,29 ± 0,0732-8,78 ± 0,06a1,664\n8. Table 3: ... LDT24-7,72 ± 0,261,57 x 10-834-8,25 ± 0,674,63 x 10-943-7,97 ± 0,798,81 x 10-953-8,35 ± 0,203,67 x 10-963-8,58 ± 0,342,16 x 10-984-8,34 ± 0,713,76 x 10-9\n9. Table 5: ... LDTα 1A (n)α 1B (n)log IC50 (M)Ki (nM)log IC50 (M)Ki (nM)62-6,51 ± 0,2261 (4)-6,27 ± 0,05448 (3)\n10. Table 6: ... LDT65-5,60 ± 0,061,5(5)66-5,92 ± 0,060,8(5)67-6,10 ± 0,060,5(5)68-6,01 ± 0,030,6(5)\n11. Table 7: ... LDTnlog CI50 ± EPM (M) aKi (M) b24-8,52 ± 0,03 **1,24 x 10-934-8,56 ± 0,07 **1,13 x 10-944-8,62 ± 0,13 **9,88 x 10-1054-8,21 ± 0,05**2,54 x 10-964-9,23 ± 0,24 *2,42 x 10-1083-10,24 ± 0,712,37 x 10-112452-8,03 ± 0,053,80 x 10-9\n12. Table 8: ... LDT5-HT1A (n)log IC50 (M)Ki (nM)62-6,47 ± 0,10147 (3)63-6,37 ± 0,03191 (3)64-6,72 ± 0,1984 (3)65-7,42 ± 0,09c18 (3)\n13. Table 10: ... LDTnlog CI50 ± EPM (M) aKi (M) b23-7,13 ± 0,114,74 x 10-833-7,15 ± 0,224,52 x 10-843-7,16 ± 0,064,42 x 10-853-6,41 ± 0,022,48 x 10-763-6,23 ± 0,463,76 x 10-783-6,41 ± 0,702,48 x 10-7\n14. Table 11: ... 5-HT2A (n)LDTlog IC50 (M)Ki (nM)62-5,00 ± 0,166,41 (3)63-4,86 ± 0,138,85 (4)64-5,06 ± 0,095,58 (3)65-5,34 ± 0,092,93 (4)\n\nNote that some of these sentences are from tables, and the formatting may not be perfect. Let me know if you'd like me to help with anything else!"
    }
]